The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.Here's the latest list of major oversold players in ...

Core Insights - The industrials sector has several oversold stocks, presenting potential buying opportunities for undervalued companies [1][2] Company Summaries - **Hertz Global Holdings Inc (NASDAQ:HTZ)**: - Recently appointed Mike Moore as Chief Operating Officer to enhance operational excellence [7] - Stock price decreased by approximately 19% over the past five days, with a 52-week low of $2.77 [7] - Current RSI value is 28.7, indicating it is oversold [7] - Shares closed at $5.60, down 10.3% on Monday [7] - Momentum score is 82.78 [7] - **Alaska Air Group Inc (NYSE:ALK)**: - Analyst Christopher Stathoulopoulos maintained a Positive rating but lowered the price target from $60 to $58 [7] - Stock fell around 24% over the past month, with a 52-week low of $39.79 [7] - Current RSI value is 24.7, indicating it is oversold [7] - Shares closed at $48.46, down 1.5% on Monday [7] - **Ambipar Emergency Response (NYSE:AMBI)**: - Reported FY24 net revenue of R$3.25 billion, reflecting a year-over-year increase of 25.4% [7] - Stock price decreased by approximately 76% over the past month, with a 52-week low of $0.72 [7] - Current RSI value is 20.9, indicating it is oversold [7] - Shares closed at $1.08, down 4.4% on Monday [7]

Core Insights - The health care sector has several oversold stocks that present buying opportunities for undervalued companies [1] - The Relative Strength Index (RSI) is a key indicator for identifying oversold conditions, typically below 30 [1] Company Summaries - **Boston Scientific Corp (BSX)**: Upgraded from Perform to Outperform by Oppenheimer analyst Steven Lichtman, with a price target raised from $118 to $125. The stock has a 52-week low of $80.64 and an RSI value of 27.3. Recent price action shows a 0.3% decline, closing at $98.23 [7] - **aTyr Pharma Inc (ATYR)**: Announced that its Phase 3 EFZO-FIT study did not meet its primary endpoint, leading to an 80% stock decline over five days. The stock has a 52-week low of $0.97 and an RSI value of 22.6. Recent price action shows a 2.4% gain, closing at $1.05 [7] - **Reviva Pharmaceuticals Holdings Inc (RVPH)**: Announced a $9 million public offering, resulting in a 21% decline over the past month. The stock has a 52-week low of $0.30 and an RSI value of 24.5. Recent price action shows a 3.7% gain, closing at $0.42 [7]

Core Insights - The energy sector has several oversold stocks that present potential buying opportunities for undervalued companies [1] Group 1: Oversold Stocks - Nextdecade Corp (NEXT) has an RSI of 27.1, with a recent stock price of $6.97 after a 30% decline over five days and a 52-week low of $4.59 [9] - XCF Global Inc (SAFX) has an RSI of 20.8, closing at $1.28 after a 7% drop over five days and a 52-week low of $1.16 [9] - Cross Timbers Royalty Trust (CRT) has an RSI of 18.6, with shares closing at $7.70 after a 12% decline over the past month and a 52-week low of $7.67 [9] - REX American Resources Corp (REX) has an RSI of 26, with shares closing at $30.46 after a 21% drop over the past month and a 52-week low of $30.32 [9]

Group 1 - The Relative Strength Index (RSI) is a technical analysis indicator that measures stock momentum on a scale of 0 to 100, with a reading below 30 indicating that a stock is oversold [1] - J&J Snack Foods Corp. (Symbol: JJSF) has an RSI reading of 29.99, indicating it has entered oversold territory, with shares trading as low as $102.46 [2][4] - The current RSI of the S&P 500 ETF (SPY) is 67.8, suggesting a significant difference in market sentiment between JJSF and the broader market [2] Group 2 - JJSF's 52-week low is $102.46, while the 52-week high is $180.80, with the last trade recorded at $102.67 [4]

Core Insights - The materials sector has several oversold stocks, presenting potential buying opportunities for undervalued companies [1][2] Group 1: Oversold Stocks - Celanese Corp has an RSI of 26.6, with a stock price of $41.80, and has fallen approximately 29% over the past month, reaching a 52-week low of $36.29 [8] - Namib Minerals has an RSI of 19.5, with a stock price of $2.93, and has experienced a significant decline of around 66% over the past month, hitting a 52-week low of $2.61 [8] - Intrepid Potash Inc has an RSI of 27.4, with shares closing at $29.01, and has decreased about 17% in the last month, with a 52-week low of $20.86 [8]

Core Viewpoint - Exelon (EXC) has experienced significant selling pressure, declining 9.2% over the past four weeks, but is now positioned for a potential trend reversal as it is in oversold territory, supported by analyst expectations of better earnings than previously predicted [1]. Group 1: Technical Indicators - The Relative Strength Index (RSI) is utilized to identify oversold stocks, with a reading below 30 indicating oversold conditions [2]. - EXC's current RSI reading is 28.78, suggesting that the heavy selling may be exhausting itself and a trend reversal could occur soon [5]. - The RSI helps investors identify potential entry opportunities when a stock is undervalued due to unwarranted selling pressure [3]. Group 2: Fundamental Indicators - There is a strong consensus among sell-side analysts that earnings estimates for EXC will improve, with a 1.3% increase in the consensus EPS estimate over the last 30 days [7]. - An upward trend in earnings estimate revisions typically correlates with price appreciation in the near term [7]. - EXC holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate trends and EPS surprises, indicating a strong potential for a turnaround [8].

Core Viewpoint - Allogene Therapeutics (ALLO) has experienced a significant decline of 31.9% over the past four weeks, but it is now in oversold territory, suggesting a potential turnaround as analysts expect better earnings than previously predicted [1]. Group 1: Stock Performance and Technical Indicators - ALLO's stock has been under heavy selling pressure, leading to an RSI reading of 25.87, indicating it is oversold [5]. - The Relative Strength Index (RSI) is a momentum oscillator that helps identify oversold conditions when the reading falls below 30 [2]. - Stocks oscillate between overbought and oversold states, and an oversold condition may present entry opportunities for investors anticipating a rebound [3]. Group 2: Analyst Sentiment and Earnings Estimates - There is a strong consensus among sell-side analysts to raise earnings estimates for ALLO, resulting in a 0.4% increase in the consensus EPS estimate over the last 30 days [7]. - An upward trend in earnings estimate revisions typically correlates with price appreciation in the near term [7]. - ALLO holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate trends and EPS surprises, indicating a strong potential for a turnaround [8].

Group 1 - Adherex Technologies Inc. (FENC) has experienced a significant downtrend, with a stock decline of 22.2% over the past four weeks, indicating strong selling pressure [1] - The stock is currently in oversold territory, as indicated by an RSI reading of 29.08, suggesting that the heavy selling may be exhausting itself and a rebound could be imminent [5] - There is a strong consensus among Wall Street analysts regarding FENC's ability to report better earnings than previously predicted, with a 124.3% increase in the consensus EPS estimate over the last 30 days [7] Group 2 - FENC holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, indicating a strong potential for a turnaround [8] - The upward trend in earnings estimate revisions typically correlates with price appreciation in the near term, further supporting the case for a potential rebound in FENC's stock price [7]

Core Viewpoint - Hyliion Holdings Corp. (HYLN) has experienced significant selling pressure, resulting in a 16.6% decline over the past four weeks, but analysts anticipate better earnings than previously expected, indicating potential for recovery [1]. Group 1: Technical Indicators - The Relative Strength Index (RSI) is utilized to identify oversold stocks, with a reading below 30 typically indicating oversold conditions [2]. - HYLN's current RSI reading is 29.79, suggesting that the stock may be nearing a reversal point due to the exhaustion of selling pressure [5]. Group 2: Fundamental Indicators - Analysts have raised earnings estimates for HYLN by 6.3% over the last 30 days, indicating a consensus among sell-side analysts that could lead to price appreciation [7]. - HYLN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks, which further supports the potential for a turnaround [8].